Search

Gleneagle to buy biotech firm for $2m

Gleneagle Gold announced its intention to exit the resources sector through the back door today, with a proposal to buy a Melbourne-based unlisted biotechnology company for a share package worth $2 million.

Login

(existing subscribers)

The password field is case sensitive.
Request new password

Add your comment

Share Transactions

30/06/15
$0 Other
30/06/15
$0 Other
30/06/15
$0 Other
Total value as at the date of the transaction
Source: Morningstar

BNiQ Disclaimer